More about that vaccine development...

Ave Maria Biotechnology LLC (AVM Biotech) offers a positive, ethical, and effective alternative to the moral hazards pervasive in the fields of biotechnology, pharmaceuticals, and vaccine development. The use of aborted fetal tissue and embryonic cells in the discovery, development, and production of vaccines and pharmaceuticals has increased dramatically in the past decade.

Without a positive alternative, obtaining new medication or vaccinations which are ethically untainted will be difficult, if not impossible. By developing moral alternatives to unethical practices, AVM Biotech seeks to relieve parents, families, medical professionals, hospitals, and health care organizations from having to choose between the health of a loved one or patient and the forced participation in a morally objectionable treatment.

Our products reflect a profound respect for human life from its beginning until its natural conclusion. Ave Maria Biotechnology Company certifies that its therapeutic products are not discovered, screened, evaluated, produced, or tainted in any way by the use of directly aborted human fetal material, human embryonic material, or any other unethically obtained materials.
For more information, please contact us at info@avemariabiotech.com


Can't find the stock info online - it must not be a publicly traded company. Yet.